StartUp Health August 20, 2024
The AI solution developed by StartUp Health company DreaMed is designed to provide treatment recommendations to millions of people with diabetes who do not have access to endocrinologists.
DreaMed, a Tel Aviv, Israel-based startup in the StartUp Health T1D Moonshot Community, raised $3M and signed several deals with health systems and companies. The company is the developer of the endo.digital platform, which provides AI-based recommendations for the treatment of people with diabetes. eHealth Ventures led this latest funding round. source>
This week’s reported health innovation funding also included:
Caresyntax, a San Francisco, CA- and Berlin, Germany-based precision surgery software and AI platform, raised $180M through an $80M Series C extension and up to $100M of growth debt expansion. Inventors...
Today's Sponsors
Today's Sponsor